By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
ODTX insiders were on both sides of the trade this year. Buys came to roughly $75.3 million (seven buyers), sales to $32,000 (one seller).
The largest purchase came from COULTER JAMES G (Other), about $25 million. C-suite participation is part of the picture here.
58 investment managers listed ODTX in their latest 13F filings (Q2 2026); more funds bought than sold. Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters.
Are insiders buying or selling ODTX stock?
In the last 12 months Odyssey Therapeutics, Inc. insiders made open-market purchases worth about $75.3 million and sales worth about $32,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in ODTX?
The most recent open-market insider trade in ODTX was filed on 2026-05-13.
How many institutions own ODTX?
58 investment managers reported holding ODTX in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded ODTX?
No congressional trades in ODTX were reported in the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).